Bajopas Volume 7 Number 2 December, 2014 http://dx.doi.org/10.4314/bajopas.v7i2.28 Bayero Journal of Pure and Applied Sciences, 7(2): 160 – 163 Received: August 2014 Accepted: December 2014 ISSN 2006 – 6996 ASSESSMENT OF THE EFFECT OF DIHYDROARTEMISININ-SODIUM VALPROATE COMBINATION ON SOME BEHAVIOURAL ACTIVITIES IN MICE Malami, S. 1, Yaro, A.H. 2, Ya’u, J. 1, Idris, A.G. 1 and Ahmadu, H.1 1Department of Pharmacology and Therapeutics, Ahmadu Bello University, Zaria, Nigeria. 2Department of Pharmacology, Bayero University, Kano, Nigeria. Correspondence author: [email protected] ABSTRACT Co-morbidity inevitably warrant occurrence of polypharmacy that may result in interactions or modification of either the therapeutic or toxic effect of any of the drugs employed. Malaria and epilepsy have been known to occur concurrently as such may necessitate the co-administration of two or more drugs. This study evaluated the effect of dihydroartemisinin-valproate combination on some behavioral activities related to central nervous system. The study was conducted using animal models as follows: maximal electroshock-induced seizures test in mice, diazepam-induced sleep in mice and mouse beam walking test for motor coordination deficit. Generally, the results showed that there were no statistical significant effects in the test models. Therefore, dihydroartemisinin did not significantly influence the protective effect of sodium valproate in convulsion; and did not significantly cause sedation in animals. Hence, the result of this study suggests that dihydroartemisinin-sodium valproate combination could be considered safe in seizures condition. Keywords: Dihydroartemisinin, Polypharmacy, Valproate, Drugs, Epilepsy INTRODUCTION MATERIALS AND METHODS Epilepsy is currently defined as the occurrence of at Animals: Seventy six Swiss Albino mice (18-24 g) of least one seizure with an enduring alteration in the both sexes were used for the experiments. They were brain structure or function that increases the likelihood obtained from Animal House, Department of of future seizures (Gerlach and Krajewski, 2010). Pharmacology and Therapeutics, Ahmadu Bello Recent estimates suggest that it accounts for 1% of University, Zaria. The animals were kept in plastic the global burden of the disease and affects over 65 cages with constant supply of standard animal feeds million people. Epilepsy is the most common and water ad libitum ; maintained at room temperature neurological disorder, affecting individuals at all age and 12 h light/dark cycle; and allowed to acclimatize groups. It remains a common childhood neurological with the laboratory environment for at least 3 days disorder in Nigeria, with large burden of symptomatic prior to the commencement of the experiments. epilepsy (Lagunju et al ., 2012). Thus, epilepsy imposes a large economic burden on global health Drugs: The following drugs were used: care systems and is a major public health problem in Dihydroartemisinin (Cotecxin- Jiaxing Nanhu China), low and middle-income countries (Mbuba and Newton, Valproate (Epillin- Sanofi UK), Diazepam (Valium- 2009). It is the most common non-infectious Roch UK). neurologic disease in developing African countries, including Nigeria and it remains a major medical and Methods social problem (Ogunrin, 2006). Malaria is a major Maximal electroshock-induced seizure test in health concern in Nigeria and other parts of Sub- mice saharan Africa (WHO, 2004). Currently, drugs for For maximal electroshock test, the method of treatment of uncomplicated malaria are Artemisinin Swinyard and Kupferberg (1985) was adopted. based combination therapies (FMH, 2005). Valproate Twenty eight mice were randomly divided in to four is known to have multiple mechanisms of action; it is groups (G) of seven mice each. G I and G II were effective in many kinds of epilepsy and relatively free given a daily dose of dihydroartemisinin (p.o.) for from unwanted effects associated with other seven days (Day 1: 2 mg/kg; Days 2-7: 1 mg/kg). On antiepileptic drugs (McNamara, 2006). This work is the day eight, 200 mg/kg of valproate was aimed at assessing the effect of co-administration of administered (p.o.) to G I and G III; and normal saline dihydroartemisinin and sodium valproate on some (10 ml/kg) to G IV. After an hour, maximal behavioural activities related to central nervous electroshock was applied to the mice to induce system in mice. seizures. Episodes of tonic hind limb extension (THLE) were observed. 160 Bajopas Volume 7 Number 2 December, 2014 Diazepam-induced sleeping time in mice Statistical Analysis The method explained by Wambebe (1985) was Results are presented in tables and expressed as employed to assess the effect of valproate and Mean ± SEM. The level of significance between means dihydroartemisinin combination on the sedative was tested by ANOVA and results were regarded as activity of diazepam in mice. Twenty four mice were statistically significant at P<0.05. randomly divided in to four groups (G) of six mice each. The G I and G II were given a daily dose of RESULTS dihydroartemisinin (p.o.) for seven days (Day 1: 2 The result showed that there was same quantal mg/kg; Days 2-7: 1 mg/kg). At the 8 th day, 200 mg/kg protection against occurrence of seizures between the of valproate was administered (p.o) to G I and G III; groups that were given valproate alone and that which and normal saline (10 ml/kg, p.o.) to G IV. After an received dihydroartemisinin and valproate (Table 1). hour post treatment, all the groups were administered Likewise there was no protection against seizures in 20 mg/kg of diazepam (i.p.); onset and duration of both normal saline and dihydroartemisinin groups. sleep were observed and recorded. Therefore, dihydroartemisinin did not affect the protective capacity of valproate against maximal Beam walking test for motor coordination electro-induced seizures. deficits in mice There was general decrease in both the onset and The method described by Stanley et al . (2005) was duration of sleep, although the decrease was not employed. Twenty four mice were randomly divided in statistically significant (Table 2). It could be said that to four groups (G) of six mice each. They were trained valproate decreases the onset of action of diazepam. to travel from a start platform along a ruler (80 cm However, the results showed that valproate shortened long, 3 cm wide) elevated 30 cm above the bench by the duration of sleep which may predict possible metal supports to a metal box. The G I and G II were ability of valproate to enhance metabolism of given a daily dose of dihydroartemisinin (p.o.) for diazepam, and hence quick recovery from sleep. seven days (Day 1: 2 mg/kg; Days 2-7: 1 mg/kg). At The result of diazepam-induced motor coordination the 8 th day, 200 mg/kg of valproate was administered deficit showed a general decrease in time taken to (p.o) to G I and G III; and normal saline (10 ml/kg, cross the beam, the decrease was significant (p<0.05) p.o.) to G IV. After an hour post treatment, all the in valproate and dihydroartemisinin-valproate treated groups were administered 0.5 mg/kg of diazepam groups (Table 3). Also, it could be said that (i.p.), they were allowed for 30 minutes then moved dihydroartemisinin reduced the motor coordination to the beam test. Time taken to move across the deficit induced by diazepam as shown from the beam and number of foot slips were observed and number of hind limb slips. But the group treated with recorded. valproate alone showed an increase in the number of hind limb slips, although it was statistically not significant. Table 1: Effect of Dihydroartemisinin-valproate combination on Maximal Electroshock - induced Seizures in Mice Group/ Quantal Protection Mean Mortality Rate Treatment Protection against Recovery Time (%) (mg/kg) Seizures (%) (min) G I DHA+VA 6/7 85.7 - 14.28 G II DHA 0/7 0.0 1.18 ± 0.30 14.28 G III VA 6/7 85.7 - 14.28 G IV N/saline 0/7 0.0 1.67 ± 0.33 14.28 Values are presented as Mean ± SEM, n = 7 per group; DHA = Dihydroartemisinin (Day 1: 2 mg/kg, Days 2-7: 1 mg/kg), VA = Valproate (200 mg/kg), N/saline= Normal saline (10 ml/kg), G = Group Table 2: Effect of Dihydroartemisinin-valproate combination on Diazepam-induced Sleep in Mice Group/Treatment Mean Onset Mean Duration (mg/kg) of sleep (min) of Sleep (min) G I DHA+VA 4.17 ± 0.48 25.00 ± 3.45 G II DHA 6.17 ± 1.48 27.80 ± 2.80 G III VA 4.83 ± 0.74 29.17 ± 8.91 G IV N/saline 7.12 ± 3.49 26.60 ± 3.50 Values are presented as Mean ± SEM, n = 6 per group, DHA= Dihydroartemisinin (Day 1: 2 mg/kg, Days 2-7: 1 mg/kg), VA= Valproate (200 mg/kg), N/saline= Normal saline (10 ml/kg), G = Group 161 Bajopas Volume 7 Number 2 December, 2014 Table 3: Effect of Dihydroartemisinin-valproate combination on Motor Coordination Deficit in Mice Group/ Number of Hind Limb Time taken for the Number of Falls Treatment Slips Task (s) (mg/kg) G I DHA+VA 5.50 ± 1.39 7.33 ± 1.92 a 0/6 G II DHA 4.83 ± 0.48 15.50 ± 3.76 0/6 G III VA 7.33 ± 0.52 9.50 ± 1.75 a 0/6 G IV N/saline+DZ 5.83 ± 1.67 21.77 ± 3.38 0/6 Values are presented as Mean ± SEM, n = 6 per group, DZ = Diazepam (20 mg/kg), DHA= Dihydroartemisinin (Day 1: 2 mg/kg, Days 2-7: 1 mg/kg), VA= Valproate (200 mg/kg), N/saline (10 ml/kg)= Normal saline, Significant at P<0.05 (ANOVA) DISCUSSION metabolism or an action on the central mechanisms The result showed that there was same quantal involved in the regulation of sleep (N’Gouemo et al ., protection against occurrence of seizures between the 1994; Amos et al ., 2001).